Gilead Sciences Inc (GILD)

68.50 +0.32  +0.47% NASDAQ Aug 14, 20:00 USD

Gilead Sciences Cash from Financing (TTM):

-6.896B for June 30, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 1990. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2020 -6.896B
March 31, 2020 -7.879B
Dec. 31, 2019 -7.634B
Sept. 30, 2019 -8.408B
June 30, 2019 -8.794B
March 31, 2019 -8.089B
Dec. 31, 2018 -12.32B
Sept. 30, 2018 -7.301B
June 30, 2018 -2.23B
March 31, 2018 -1.958B
Dec. 31, 2017 3.393B
Sept. 30, 2017 -2.302B
June 30, 2017 -1.675B
March 31, 2017 -2.356B
Dec. 31, 2016 -9.725B
Sept. 30, 2016 -11.84B
June 30, 2016 -7.995B
March 31, 2016 -11.78B
Dec. 31, 2015 -5.884B
Sept. 30, 2015 -185.00M
June 30, 2015 -12.60B
March 31, 2015 -8.631B
Dec. 31, 2014 -3.025B
Sept. 30, 2014 -5.104B
June 30, 2014 -274.35M
   
March 31, 2014 539.00M
Dec. 31, 2013 -2.544B
Sept. 30, 2013 -2.209B
June 30, 2013 -1.574B
March 31, 2013 -1.492B
Dec. 31, 2012 563.00M
Sept. 30, 2012 4.600B
June 30, 2012 4.031B
March 31, 2012 3.134B
Dec. 31, 2011 1.764B
Sept. 30, 2011 -2.223B
June 30, 2011 -1.076B
March 31, 2011 -869.63M
Dec. 31, 2010 -1.339B
Sept. 30, 2010 -1.203B
June 30, 2010 -1.899B
March 31, 2010 -889.66M
Dec. 31, 2009 -1.051B
Sept. 30, 2009 -1.314B
June 30, 2009 -1.023B
March 31, 2009 -930.59M
Dec. 31, 2008 -1.475B
Sept. 30, 2008 -872.34M
June 30, 2008 -683.70M
March 31, 2008 -975.24M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Benchmarks

Benchmarks
Amgen Inc -4.267B
Johnson & Johnson -12.64B
Eli Lilly and Co -4.373B

Cash from Financing (TTM) Range, Past 5 Years

Minimum -12.32B Dec 2018
Maximum 3.393B Dec 2017
Average -6.093B
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.